Depending on the terms of any given transaction, shareholders may receive cash, stock from the acquiring company, stock in a new company created as a result of the merger, or any combination thereof. Moreover, in certain types of transactions, shareholders may receive “contingent value rights,” which offer the potential of additional payment in the future if the post-merger companies realize certain designated achievements, such as the approval of a new drug or recording a certain amount of sales.